Nov 12, 2025 08:14AM

Oct 20, 2025 08:18AM

Oct 20, 2025 06:56AM

Oct 13, 2025 06:29AM

Sep 30, 2025 08:05AM

Sep 18, 2025 06:39AM

Sep 16, 2025 08:01AM FDA grants Fast Track status to Corbus' CRB-701 for head and neck cancer

Sep 11, 2025 08:18AM

Aug 5, 2025 09:16AM

Jun 30, 2025 08:19AM

Jun 2, 2025 06:56AM

May 21, 2025 06:42AM

May 7, 2025 07:17AM

May 6, 2025 04:27PM Corbus Pharma (CRBP) Misses Q1 EPS by 139c

Mar 28, 2025 08:01AM

Mar 12, 2025 06:40AM

Mar 11, 2025 04:26PM

Feb 28, 2025 02:14AM

Feb 18, 2025 06:48AM

Feb 14, 2025 07:31AM

Feb 11, 2025 07:30AM Corbus Pharma (CRBP) to Present Clinical Data for CRB-701

Feb 10, 2025 06:41AM

Jan 2, 2025 12:51PM

Dec 17, 2024 07:04AM

Dec 9, 2024 07:04AM

Dec 3, 2024 07:00AM

Dec 2, 2024 04:10AM

Nov 7, 2024 12:48PM Oppenheimer Reiterates Outperform Rating on Corbus Pharmaceuticals (CRBP)

Nov 4, 2024 07:02AM

Oct 21, 2024 06:17AM

Sep 23, 2024 07:05AM

Sep 23, 2024 06:38AM

Sep 20, 2024 01:04PM

Sep 20, 2024 09:32AM

Sep 20, 2024 09:00AM Corbus Pharma (CRBP) Quickly Falls 52%

Sep 20, 2024 09:00AM

Sep 13, 2024 06:52AM

Aug 27, 2024 05:05AM

Aug 7, 2024 07:45AM

Aug 6, 2024 09:12AM

Jun 26, 2024 02:23AM

Jun 11, 2024 06:12AM Corbus Pharmaceuticals (CRBP) PT Raised to $82 at RBC Capital

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All